TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123 Life Science
CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer’s regorafenib Life Science
Healthcare Roundup – Innovative Industrial Properties prices public offering, Bayer cuts stake in CRISPR Therapeutics Life Science
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market Life Science
Shineco, Inc. Enters into Strategic Cooperation Agreement with Pacific Islands Trade & Investment Commission Cannabis, Life Science
Procter & Gamble says it is monitoring China coronavirus and its impact on travel, consumer confidence Life Science
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody Life Science
Healthcare Roundup – Zai Lab launches equity offering, Lilly to invest $470M in North Carolina site Life Science
